267 related articles for article (PubMed ID: 16510595)
1. Lysophosphatidic acid is a major regulator of growth-regulated oncogene alpha in ovarian cancer.
Lee Z; Swaby RF; Liang Y; Yu S; Liu S; Lu KH; Bast RC; Mills GB; Fang X
Cancer Res; 2006 Mar; 66(5):2740-8. PubMed ID: 16510595
[TBL] [Abstract][Full Text] [Related]
2. LPA1 receptors mediate stimulation, whereas LPA2 receptors mediate inhibition, of migration of pancreatic cancer cells in response to lysophosphatidic acid and malignant ascites.
Komachi M; Tomura H; Malchinkhuu E; Tobo M; Mogi C; Yamada T; Kimura T; Kuwabara A; Ohta H; Im DS; Kurose H; Takeyoshi I; Sato K; Okajima F
Carcinogenesis; 2009 Mar; 30(3):457-65. PubMed ID: 19129242
[TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells.
Park SJ; Lee KP; Kang S; Chung HY; Bae YS; Okajima F; Im DS
Cell Signal; 2013 Nov; 25(11):2147-54. PubMed ID: 23838008
[TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidic acid receptor 2 and Gi/Src pathway mediate cell motility through cyclooxygenase 2 expression in CAOV-3 ovarian cancer cells.
Jeong KJ; Park SY; Seo JH; Lee KB; Choi WS; Han JW; Kang JK; Park CG; Kim YK; Lee HY
Exp Mol Med; 2008 Dec; 40(6):607-16. PubMed ID: 19116446
[TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidic acid (LPA)-induced vascular endothelial growth factor (VEGF) by mesothelial cells and quantification of host-derived VEGF in malignant ascites.
Sako A; Kitayama J; Shida D; Suzuki R; Sakai T; Ohta H; Nagawa H
J Surg Res; 2006 Jan; 130(1):94-101. PubMed ID: 16171822
[TBL] [Abstract][Full Text] [Related]
6. Endogenous RGS proteins attenuate Galpha(i)-mediated lysophosphatidic acid signaling pathways in ovarian cancer cells.
Hurst JH; Henkel PA; Brown AL; Hooks SB
Cell Signal; 2008 Feb; 20(2):381-9. PubMed ID: 18083345
[TBL] [Abstract][Full Text] [Related]
7. Evidence for tight coupling of Gi protein-mediated lysophosphatidic acid receptor to stimulated cytokine production in ovarian cancer cell.
Sugiyama M; Imai A; Furui T; Tamaya T
Am J Obstet Gynecol; 2004 Mar; 190(3):680-5. PubMed ID: 15041999
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic acid stimulates cell growth by different mechanisms in SKOV-3 and Caov-3 ovarian cancer cells: distinct roles for Gi- and Rho-dependent pathways.
Hurst JH; Hooks SB
Pharmacology; 2009; 83(6):333-47. PubMed ID: 19420982
[TBL] [Abstract][Full Text] [Related]
9. Cancer-derived lysophosphatidic acid stimulates differentiation of human mesenchymal stem cells to myofibroblast-like cells.
Jeon ES; Moon HJ; Lee MJ; Song HY; Kim YM; Cho M; Suh DS; Yoon MS; Chang CL; Jung JS; Kim JH
Stem Cells; 2008 Mar; 26(3):789-97. PubMed ID: 18065393
[TBL] [Abstract][Full Text] [Related]
10. A growth-related oncogene/CXC chemokine receptor 2 autocrine loop contributes to cellular proliferation in esophageal cancer.
Wang B; Hendricks DT; Wamunyokoli F; Parker MI
Cancer Res; 2006 Mar; 66(6):3071-7. PubMed ID: 16540656
[TBL] [Abstract][Full Text] [Related]
11. Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy.
Miyamoto S; Hirata M; Yamazaki A; Kageyama T; Hasuwa H; Mizushima H; Tanaka Y; Yagi H; Sonoda K; Kai M; Kanoh H; Nakano H; Mekada E
Cancer Res; 2004 Aug; 64(16):5720-7. PubMed ID: 15313912
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of interleukin-6 in human ovarian cancer cell via a Gi/PI3K-Akt/NF-kappaB pathway by lysophosphatidic acid, an ovarian cancer-activating factor.
Chou CH; Wei LH; Kuo ML; Huang YJ; Lai KP; Chen CA; Hsieh CY
Carcinogenesis; 2005 Jan; 26(1):45-52. PubMed ID: 15471896
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells.
Hu YL; Tee MK; Goetzl EJ; Auersperg N; Mills GB; Ferrara N; Jaffe RB
J Natl Cancer Inst; 2001 May; 93(10):762-8. PubMed ID: 11353786
[TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidic acid regulates blood glucose by stimulating myotube and adipocyte glucose uptake.
Yea K; Kim J; Lim S; Park HS; Park KS; Suh PG; Ryu SH
J Mol Med (Berl); 2008 Feb; 86(2):211-20. PubMed ID: 17924084
[TBL] [Abstract][Full Text] [Related]
15. Rho-dependent, Rho kinase-independent inhibitory regulation of Rac and cell migration by LPA1 receptor in Gi-inactivated CHO cells.
Sugimoto N; Takuwa N; Yoshioka K; Takuwa Y
Exp Cell Res; 2006 Jun; 312(10):1899-908. PubMed ID: 16564043
[TBL] [Abstract][Full Text] [Related]
16. GROalpha is highly expressed in adenocarcinoma of the colon and down-regulates fibulin-1.
Wen Y; Giardina SF; Hamming D; Greenman J; Zachariah E; Bacolod MD; Liu H; Shia J; Amenta PS; Barany F; Paty P; Gerald W; Notterman D
Clin Cancer Res; 2006 Oct; 12(20 Pt 1):5951-9. PubMed ID: 17062666
[TBL] [Abstract][Full Text] [Related]
17. Cell type-selective pathways and clinical associations of lysophosphatidic acid biosynthesis and signaling in the ovarian cancer microenvironment.
Reinartz S; Lieber S; Pesek J; Brandt DT; Asafova A; Finkernagel F; Watzer B; Nockher WA; Nist A; Stiewe T; Jansen JM; Wagner U; Konzer A; Graumann J; Grosse R; Worzfeld T; Müller-Brüsselbach S; Müller R
Mol Oncol; 2019 Feb; 13(2):185-201. PubMed ID: 30353652
[TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidic acid and endothelin-induced proliferation of ovarian cancer cell lines is mitigated by neutralization of granulin-epithelin precursor (GEP), a prosurvival factor for ovarian cancer.
Kamrava M; Simpkins F; Alejandro E; Michener C; Meltzer E; Kohn EC
Oncogene; 2005 Oct; 24(47):7084-93. PubMed ID: 16044162
[TBL] [Abstract][Full Text] [Related]
19. A novel laminin-induced LPA autocrine loop in the migration of ovarian cancer cells.
Sengupta S; Xiao YJ; Xu Y
FASEB J; 2003 Aug; 17(11):1570-2. PubMed ID: 12824286
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms for lysophosphatidic acid-induced cytokine production in ovarian cancer cells.
Fang X; Yu S; Bast RC; Liu S; Xu HJ; Hu SX; LaPushin R; Claret FX; Aggarwal BB; Lu Y; Mills GB
J Biol Chem; 2004 Mar; 279(10):9653-61. PubMed ID: 14670967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
